Homeβ€ΊSearchβ€ΊInfection and Drug Resistance

Infection and Drug Resistance

Dove Medical Press Ltd Β· New Zealand Β· Est. 1885

ISSN1178-6973eISSN1178-6973
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
16
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.791
H-Indexi
93
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.004
Total Worksi
4,796
Total Citationsi
82,250
2yr Mean Citednessi
2.19
Open Impact Factor alternative
Retractions
6
Source: Retraction Watch

Aims & Scope

An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.

General Information

Country / RegionNew Zealand
Primary LanguageEnglish
1st Year Published1885
FrequencyIrregular
StatusActive (last: 2026)
Total Publications4,796
Publisher OrgDove Medical Press
OA Since2007
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~16 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
Dove Medical Press Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1178-6973 / 1178-6973
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
384
13k
2019
470
15k
2020
551
12k
2021
735
9.4k
2022
705
7.4k
2023
563
2.5k
2024
598
1.2k
2025
375
37
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Infectious DiseasesQ2
PharmacologyQ2
Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Infectious DiseasesPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Infectious Diseases

Research Topics (OpenAlex)

Antibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyBacterial Identification and Susceptibility TestingAntibiotic Use and ResistanceAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICUAntimicrobial Resistance in StaphylococcusPneumonia and Respiratory InfectionsAntifungal resistance and susceptibilityMycobacterium research and diagnosis

Frequently asked questions about Infection and Drug Resistance

Is Infection and Drug Resistance a predatory journal?

PubScope has no integrity flags on record for Infection and Drug Resistance: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Infection and Drug Resistance?

Infection and Drug Resistance is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.19.

Is Infection and Drug Resistance indexed in Scopus and Web of Science?

Infection and Drug Resistance is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Infection and Drug Resistance?

An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref